< 生产厂家价格 >

4-乙酰基-5-氧己酸乙酯

4-乙酰基-5-氧己酸乙酯名称

[ CAS 号 ]:
2832-10-2

[ 中文名 ]:
4-乙酰基-5-氧己酸乙酯

[ 英文名 ]:
ethyl 4-acetyl-5-oxohexanoate

[中文别名 ]:

[英文别名 ]:

ethyl 5-oxo-4-acetylhexanoate
4-Acetyl-5-oxohexanoic Acid Ethyl Ester
Ethyl 4,4-Diacetylbutyrate
4,4-Diacetylbutyric Acid Ethyl Ester
Ethyl 4-Acetyl-5-oxohexanoate
ethyl 4-acetyl-5-oxo-hexanoate
MFCD00009211
3-Ethoxycarbonylethyl-2,4-pentanedione
4-acetyl-5-oxo-hexanoic acid ethyl ester
3-acetyl-5-oxohexanoate

4-乙酰基-5-氧己酸乙酯物理化学性质

[ 密度 ]:
1.067 g/mL at 25 °C(lit.)

[ 沸点 ]:
153-154 °C19 mm Hg(lit.)

[ 分子式 ]:
C₁₀H₁₆O₄

[ 分子量 ]:
200.23200

[ 闪点 ]:
>230 °F

[ 精确质量 ]:
200.10500

[ PSA ]:
60.44000

[ LogP ]:
1.12390

[ 外观性状 ]:
透明黄色液体

[ 蒸汽压 ]:
3.97E-05mmHg at 25°C

[ 折射率 ]:
n20/D 1.457(lit.)

[ 储存条件 ]:
室温

4-乙酰基-5-氧己酸乙酯MSDS

4-乙酰基-5-氧己酸乙酯安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves

[ 安全声明 (欧洲) ]:
S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2918300090

4-乙酰基-5-氧己酸乙酯合成路线

4-乙酰基-5-氧己酸乙酯上下游产品

4-乙酰基-5-氧己酸乙酯上游产品

4-乙酰基-5-氧己酸乙酯下游产品

4-乙酰基-5-氧己酸乙酯海关

[ 海关编码 ]: 2918300090

[ 中文概述 ]:
2918300090 其他含醛基或酮基不含其他含氧基羧酸（包括酸酐、酰卤化物、过氧化物和过氧酸及该税号的衍生物）. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:6.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2918300090 other carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%

4-乙酰基-5-氧己酸乙酯文献

Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.

J. Med. Chem. 49 , 3963-72, (2006)

In a continuing study of curcumin analogues as potential drug candidates to treat prostate cancer at both androgen-dependent and androgen-refractory stages, we designed and synthesized over 40 new ana...

Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.

J. Med. Chem. 45(23) , 5037-42, (2002)

A number of curcumin analogues were prepared and evaluated as potential androgen receptor antagonists against two human prostate cancer cell lines, PC-3 and DU-145, in the presence of androgen recepto...

更多文献